HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials [Breast Cancer]

Conclusion
Our findings support the original categorizations of HER2 by FISH status in BCIRG/Translational Research in Oncology trials.

Source: Journal of Clinical Oncology - October 4, 2016 Category: Cancer & Oncology Authors: Press, Sauter, Buyse, Fourmanoir, Quinaux, Tsao-Wei, Eiermann, Robert, Pienkowski, Crown, Martin, Valero, Mackey, Bee, Ma, Villalobos, Campeau, Mirlacher, Lindsay, Slamon Tags: Diagnosis & Staging, Combined Modality, Clinical Trials, Prognostic Studies, ASCO Guidelines, Breast Cancer, Cancer Biomarkers, Growth Factors & Receptor, Oncogenes Source Type: research